PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
25-Jun-2022 MagForce AG issues Bearer Notes with a total Volume of up to EUR 3.5 Million to Lansdowne Investment Company Cyprus Limited MagForce AG
24-Jun-2022 FYB201, Formycon's biosimilar for Lucentis® (ranibizumab), receives CHMP recommendation from EMA Formycon AG
24-Jun-2022 ​​​​​​​PAION REPORTS SOLID PROGRESS WITH COMMERCIAL ACTIVITIES IN EUROPE PAION AG
24-Jun-2022 Kinarus Therapeutics to host KOL event on Monday, June 27, to discuss therapies in wet Age-Related Macular Degeneration and potential advantages of KIN001 Kinarus Therapeutics Holding AG
23-Jun-2022 Medacta Announces First Lumbar Fusion Procedure with NextAR Augmented Reality Surgical Platform in Australia Medacta Group SA
23-Jun-2022 Adrenomed appoints Dr. med. Steffen Stürzebecher as Chief Medical Officer Adrenomed AG
23-Jun-2022 APONTIS PHARMA AG: Notice according to Article 2 paragraph 1 of Delegated Regulation (EU) 2016/1052 APONTIS PHARMA AG
23-Jun-2022 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Positive Independent Data Safety Monitoring Board Recommendation for Phase 2b Study of Varoglutamstat in AD (news with additional features) Vivoryon Therapeutics N.V.
22-Jun-2022 Biophytis: Results of the Combined General Meeting on June 21, 2022 All ordinary and extraordinary resolutions presented by the company have been adopted Biophytis
22-Jun-2022 CureVac Announces Voting Results of General Meeting CureVac
22-Jun-2022 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Outcome of Annual General Meeting 2022 (news with additional features) Vivoryon Therapeutics N.V.
22-Jun-2022 Evotec SE reports results of Annual General Meeting 2022 Evotec SE
22-Jun-2022 Besins Healthcare Group acquires hormonal gel manufacturing site Besins Healthcare
22-Jun-2022 Labcorp Enhances Clinical Trial and Drug Development Capabilities Through Real World Data Collaboration With HealthVerity Labcorp
22-Jun-2022 Truveta Announces Strategic Collaboration with Pfizer to Accelerate Safety Insights in Real Time Pfizer
21-Jun-2022 ANALOG PHARMA AND DIPHARMA ANNOUNCE US FDA APPROVAL OF ABBREVIATED NEW DRUG APPLICATION (ANDA) OF GENERIC NITISINONE CAPSULES (TEMPERATURE STABLE) Analog Pharma
21-Jun-2022 Achilles Therapeutics Recognized with the 2022 PING Innovation Award Achilles Therapeutics
21-Jun-2022 Medios AG successfully holds Annual General Meeting 2022 Medios AG
21-Jun-2022 Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Drug Application (NDA) for ACER-001 Relief Therapeutics Holding SA
21-Jun-2022 Alnylam UK and Refugee Action Launch 3-year Corporate ‘Challengers’ Partnership Aimed at Preparing More Refugees for Employment in the UK Alnylam Pharmaceuticals